RiverVest Venture Partners®, a venture capital firm investing in emerging medical technology and biopharmaceutical companies, today announced the promotion of Niall O’Donnell, Ph.D., to principal. Dr. O’Donnell joined RiverVest as a Kauffman Fellow in May 2006 and has continued his work as an associate since completing his fellowship in July 2008.
RiverVest Venture Partners announced today that it has completed fundraising for its second fund, RiverVest Venture Fund II, L.P., with total committed capital of $75 million from private investors. RiverVest’s first fund, which was licensed as a Small Business Investment Company, had total private capital of $45 million,plus one tier of leverage from the Small Business Administration.
RiverVest Venture Partners, a life science venture capital firm headquartered in St. Louis, MO, announced today that it will be opening an office at the BioEnterprise facility in Cleveland, OH. The office will be managed by Karen Spilizewski, who is joining RiverVest on a part-time basis as a vice president on January 1, 2008.
RiverVest Venture Partners®, a venture capital firm investing nationwide in emerging medical technology and biopharmaceutical companies, today announced that Gordon Foulkes, Ph.D., has joined the firm as a Venture Partner.
RiverVest Venture Partners®, a venture capital firm investing nationwide in emerging medical technology and biopharmaceutical companies, has named Dennis Wahr, M.D., to the position of managing director. Wahr, a specialist in cardiac medicine, brings to the firm more than 25 years of experience in clinical practice and medical device entrepreneurship.
RiverVest Venture Partners, a national venture capital firm focusing on seed and early-stage life sciences investments, has named Scott R. Naisbitt, M.D., Ph.D. an associate and Floyd E. Bloom, M.D., a scientific advisor. Dr. Naisbitt brings a broad background in molecular biology, neuroscience and clinical medicine to RiverVest. Prior to joining the firm, he was an associate of Seedling Enterprises…
RiverVest Venture Partners announced today that the fundraising for RiverVest Venture Fund I, L.P. is complete, closing with $89 million of capital under management. The firm’s founders and managing directors are Andrew B. Craig III, Thomas C. Melzer, Jay W. Schmelter and Mark J. Mendel, Ph.D.